American Origin Unverified
This profile is unclaimed and has not been independently reviewed.
Claim & get verified
CytoDyn Inc.
$0.30
+2.15%
OTC: CYDY · 15-min delayed
$0Revenue · FY2023
$3.7MNet income
CYDYOTC
About CytoDyn Inc.
CYTODYN INC
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Reported figures
Financial summary
- Revenue FY2023
- $0
- Net income
- $3.7M
- Total assets
- $18.0M
Source: SEC EDGAR · updated Jun 7, 2026
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
Market data by Polygon.io · prices are 15-minute delayed
Auto-generated
At a glance
- Profitable — net income of $3.7M in FY2023.
- Trading 30% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review CytoDyn Inc..
Write a review
Newsroom
News about CytoDyn Inc.
CytoDyn Announces Settlement with Amarex Clinical Research LLC - GlobeNewswire
CytoDyn Announces Start of Preclinical MASH Study, Results Expected in Fall 2024
CytoDyn to Host Webcast to Provide Company Update
May 2024 Letter to Shareholders
News & sentiment via Polygon.io
Explore
Browse all →
